Product
Pneumococcal 13-valent Conjugate Vaccine
Aliases
PCV 13, PCV13 Vaccine, Pneumococcal 13-valent Conjugate Vaccine (PCV13), Prevnar 13 (2 other aliases)
Name
PREVNAR 13
INN Name
pneumococcal 13-valent conjugate vaccine
FDA Approved
Yes
10 clinical trials
1 organization
29 indications
1 document
Indication
Volunteers (Meningococcal Infection)Indication
Pneumococcal InfectionsIndication
Pneumococcal ImmunizationIndication
DiphtheriaIndication
Tetanus ImmunisationIndication
Pertussis ImmunisationIndication
Hepatitis B ImmunizationIndication
Polio ImmunizationIndication
Measles ImmunizationIndication
Rubella vaccinationIndication
Varicella VaccinationIndication
Mumps ImmunizationIndication
Plasma Cell NeoplasmIndication
Chronic Lymphocytic LeukemiaIndication
Small Lymphocytic LymphomaIndication
Aggressive Non-Hodgkin LymphomaIndication
Indolent Non-Hodgkin LymphomaIndication
Recurrent Diffuse Large B-Cell LymphomaIndication
Recurrent Follicular LymphomaIndication
Mantle Cell LymphomaIndication
Marginal Zone LymphomaIndication
Non-Hodgkin LymphomaIndication
Recurrent T-Cell Non-Hodgkin LymphomaIndication
Hepatocellular CarcinomaIndication
Intrahepatic CholangiocarcinomaIndication
intrahepatic cholangiocarcinomaClinical trial
A Randomized Study to Describe the Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersStatus: Completed, Estimated PCD: 2023-03-16
Clinical trial
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersStatus: Completed, Estimated PCD: 2023-10-20
Clinical trial
A Phase I, Double-Blind, Randomized, Multicenter Trial of the Safety,Tolerability, and Immunogenicity of V114 in Healthy Japanese InfantsStatus: Completed, Estimated PCD: 2020-06-24
Clinical trial
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South AfricaStatus: Completed, Estimated PCD: 2023-01-28
Clinical trial
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsStatus: Completed, Estimated PCD: 2023-08-10
Clinical trial
Safety and Immunogenicity of a 3-Dose Schedule of an Investigational Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersStatus: Completed, Estimated PCD: 2022-02-18
Clinical trial
Influenza Vaccination in Plasma Cell DyscrasiasStatus: Completed, Estimated PCD: 2021-05-11
Clinical trial
Early Intervention Trial of Ibrutinib for Patients With Asymptomatic, High-Risk Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Phase I/II Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation and Anti-PD-1 Antibody (Pembrolizumab) for Patients With Non-Hodgkin LymphomaStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Clinical trial
Study of Intratumoral Injection of Dendritic Cells After High-Dose Conformal External Beam Radiotherapy in Patients With Unresectable Liver CancerStatus: Recruiting, Estimated PCD: 2027-08-31
Document
DailyMed Label: PREVNAR 13Organization
A-S Medication Solutions